Fresnillo (LSE: FRES): Can the world’s largest silver miner hold its record gains as 2026 output dips?
TCS CEO corrects three major Nashik facts: Nida Khan was not HR head, unit not shut, no POSH complaints on record
Read More Pharma Industry News Chimeric Therapeutics secures new funding boost as cancer cell therapy trials accelerate Discover how Chimeric Therapeutics' A$1M entitlement offer will drive innovation across CAR-T and NK cell therapy programs. Read the full story here. byPallavi MadhirajuApril 27, 2025